Cargando…
Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease
Arthritogenic alphaviruses are a group of medically important arboviruses that cause inflammatory musculoskeletal disease in humans with debilitating symptoms, such as arthralgia, arthritis, and myalgia. The arthritogenic, or Old World, alphaviruses are capable of causing explosive outbreaks, with s...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466158/ https://www.ncbi.nlm.nih.gov/pubmed/30909385 http://dx.doi.org/10.3390/v11030290 |
_version_ | 1783411045521424384 |
---|---|
author | Mostafavi, Helen Abeyratne, Eranga Zaid, Ali Taylor, Adam |
author_facet | Mostafavi, Helen Abeyratne, Eranga Zaid, Ali Taylor, Adam |
author_sort | Mostafavi, Helen |
collection | PubMed |
description | Arthritogenic alphaviruses are a group of medically important arboviruses that cause inflammatory musculoskeletal disease in humans with debilitating symptoms, such as arthralgia, arthritis, and myalgia. The arthritogenic, or Old World, alphaviruses are capable of causing explosive outbreaks, with some viruses of major global concern. At present, there are no specific therapeutics or commercially available vaccines available to prevent alphaviral disease. Infected patients are typically treated with analgesics and non-steroidal anti-inflammatory drugs to provide often inadequate symptomatic relief. Studies to determine the mechanisms of arthritogenic alphaviral disease have highlighted the role of the host immune system in disease pathogenesis. This review discusses the current knowledge of the innate immune response to acute alphavirus infection and alphavirus-induced immunopathology. Therapeutic strategies to treat arthritogenic alphavirus disease by targeting the host immune response are also examined. |
format | Online Article Text |
id | pubmed-6466158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64661582019-04-18 Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease Mostafavi, Helen Abeyratne, Eranga Zaid, Ali Taylor, Adam Viruses Review Arthritogenic alphaviruses are a group of medically important arboviruses that cause inflammatory musculoskeletal disease in humans with debilitating symptoms, such as arthralgia, arthritis, and myalgia. The arthritogenic, or Old World, alphaviruses are capable of causing explosive outbreaks, with some viruses of major global concern. At present, there are no specific therapeutics or commercially available vaccines available to prevent alphaviral disease. Infected patients are typically treated with analgesics and non-steroidal anti-inflammatory drugs to provide often inadequate symptomatic relief. Studies to determine the mechanisms of arthritogenic alphaviral disease have highlighted the role of the host immune system in disease pathogenesis. This review discusses the current knowledge of the innate immune response to acute alphavirus infection and alphavirus-induced immunopathology. Therapeutic strategies to treat arthritogenic alphavirus disease by targeting the host immune response are also examined. MDPI 2019-03-22 /pmc/articles/PMC6466158/ /pubmed/30909385 http://dx.doi.org/10.3390/v11030290 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mostafavi, Helen Abeyratne, Eranga Zaid, Ali Taylor, Adam Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease |
title | Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease |
title_full | Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease |
title_fullStr | Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease |
title_full_unstemmed | Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease |
title_short | Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease |
title_sort | arthritogenic alphavirus-induced immunopathology and targeting host inflammation as a therapeutic strategy for alphaviral disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466158/ https://www.ncbi.nlm.nih.gov/pubmed/30909385 http://dx.doi.org/10.3390/v11030290 |
work_keys_str_mv | AT mostafavihelen arthritogenicalphavirusinducedimmunopathologyandtargetinghostinflammationasatherapeuticstrategyforalphaviraldisease AT abeyratneeranga arthritogenicalphavirusinducedimmunopathologyandtargetinghostinflammationasatherapeuticstrategyforalphaviraldisease AT zaidali arthritogenicalphavirusinducedimmunopathologyandtargetinghostinflammationasatherapeuticstrategyforalphaviraldisease AT tayloradam arthritogenicalphavirusinducedimmunopathologyandtargetinghostinflammationasatherapeuticstrategyforalphaviraldisease |